Search for: "PHARMACEUTICAL IP HOLDINGS, INC."
Results 1 - 20
of 169
Sorted by Relevance
|
Sort by Date
19 Aug 2019, 9:20 am
Safe-Run in the Chinese Supreme People’s Court, which clarified the standard of filing a declaratory judgment action of non-infringement of patent.Patently-O reports on Nalpropion Pharmaceuticals, Inc. v. [read post]
28 May 2007, 8:21 pm
VP & Chief IP Counsel, Allergan, Inc. and author of The Generic Challenge) and Robert C. [read post]
23 Jun 2010, 10:28 pm
Anchen Pharmaceuticals, Inc. [read post]
31 Dec 2023, 4:29 pm
Copyright Fair Use Andy Warhol Foundation for the Visual Arts, Inc. v. [read post]
24 Mar 2010, 4:45 am
Synthon Pharmaceuticals, Inc. [read post]
28 Sep 2010, 3:14 pm
Teva Pharmaceuticals USA Inc. et al. [read post]
11 Jan 2008, 9:00 am
: (Biotech Weblog),Immunomedics obtains antibody patent: (SmartBrief),Cyplasin Biomedical obtains US patent for protein based cancer treatment: (Patent Docs)Argatroban - Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds… [read post]
17 Jan 2008, 10:00 pm
: (Against Monopoly),Structuring a decentralized world - Institute for Ethics and Emerging Technologies: The necessity of open biotechnology: (Patent Lens),A skeptical look at the Automated Content Access Protocol: (Ars Technica),5 practical things to incorporate in a corporate IP strategy: (IP ThinkTank), Legal models for online content enforcement: (OpenContentLawyer),Germany, Chinese copies and misdirected… [read post]
12 Oct 2010, 8:56 pm
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
18 Aug 2010, 12:19 am
King Pharmaceuticals, Inc. v. [read post]
11 Jun 2019, 7:43 am
[Watch Here] Today’s witnesses are primarily business leaders and in-house attorneys for large IP-focused businesses: Panel I Manny Schecter, Chief Patent Counsel at IBM Laurie Self, Senior Vice-President and Counsel at Qualcomm Byron Holz, Senior Counsel at Nokia Kim Chotkowski, VP at InterDigital Sean Reilly, Associate General Counsel at The Clearing House Payments Company Panel II Laurie Hill, VP for IP at Genentech Sean George, CEO at… [read post]
6 Oct 2010, 4:22 am
Sandoz, Inc. et al (Docket Report) [read post]
15 Jun 2011, 4:56 am
Par Pharmaceutical, Inc. [read post]
7 Sep 2010, 6:10 pm
Genpharm Inc. et al. [read post]
29 Feb 2008, 8:00 am
, (EDTexweblog.com), (Patent Prospector), (Peter Zura's 271 Patent Blog), (IPBiz), (Against Monopoly), (Philip Brooks), (IPBiz), Indian government to consider whether to grant compulsory licenses to Natco for the exportation of generic versions of Tarceva and Sutent (Sunitinib) to Nepal : (Spicy IP), (Spicy IP), (Spicy IP), (Generic Pharmaceuticals & IP), (IP Law360), (Spicy IP),GlobalGlobal - GeneralIntellectual privilege… [read post]
5 Jan 2008, 6:00 am
You can separately subscribe to the IP Think Tank Global week in Review at [feeds.feedburner.com]GlobalComing out of copyright - some notable deaths from 1937: (IPKat),Design patents: No longer the province of individual inventors: (Patently O),Fail fast, ready fire aim and Stanford v Cal: (IP Think Tank),Walls, Alexander the Great and Partha Bose: (IP Think Tank),A fair use primer for online content creators: (Ars … [read post]
13 Jan 2010, 3:00 am
Actavis Elizabeth LLC (Docket Report) US: Inclusion of Pay-for-Delay ban in Health Care Bill urged; FTC to hold press conference announcing pay-for-delay analysis (FDA Law Blog) US: Drug molecules going off patent in 2010 (Patentcircle) Products Cipramil (Citalopram) - EU: Commission opens antitrust investigation into pharmaceutical company Lundbeck (EPLAW) (Managing IP) (GenericsWeb) Hectorol (Doxercalciferol) - US: Genzyme files patent infringement complaint… [read post]
8 Dec 2007, 11:00 am
: (IP Think Tank), WIPO - Idris gets paid out to leave early: (IAM), (Patent Prospector), Deutsche Grammophon ditches DRM: (ArsTechnica)PharmaFDA revisits NCE exclusivity for enantiomers: (Arnall Golden & Gregory), Accupril (Quinapril) - Judge finds against Teva and holds Warner-Lambert patent enabled: (IPLaw360), (OrangeBookBlog), Altace / Tritace / Ramace (Ramipril) - King Pharmaceuticals loses CAFC rehearing… [read post]
29 Jul 2011, 11:13 pm
(Patent Docs) Cenestin (Synthetic conjugated estrogens) – US: CAFC: Prosecution history estoppel bars Duramed’s allegations of infringement under doctrine of equivalents: Duramed Pharmaceuticals, Inc. v. [read post]
1 Dec 2007, 9:00 am
pharmaceutical companies: (SpicyIP),Great discussion on pharmaceuticals, patents and incentives for innovation: (Generic Pharmaceuticals & IP), (DrugWonks),Adenoscan (Adenosine) - Astellas Pharma, King Pharmaceuticals, and Teva Settle Adenoscan ® Patent Suit: (PatentDocs), Clarinex (Desloratadine) - Schering Corp. adds Anchen Pharmaceuticals Inc. to the long list of companies sued for patent infringement: (IPLaw360),… [read post]
